Home Compare APP vs ZEAL.CO
Stock Comparison · Valuation-led comparison

AppLovin vs Zealand Pharma A/S: Which Stock Looks Stronger in 2026?

Zealand Pharma A/S holds the cleaner structural position, with valuation as the main driver and stability adding further support. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison is mainly decided in valuation, with the rest of the profile carrying less weight. The overall score gap is 14 points in favour of Zealand Pharma A/S.

Trajectory Similarity
0.65
Moderately similar
Peer-set rank: #6
within AppLovin Corporation's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The clearest structural overlap shows up in operating margin level and investment intensity.

Similarity drivers
operating margin levelinvestment intensity
What reduces the match
recent revenue growth
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
APP
AppLovin Corporation
70
Peer-Score
Signal qualityMedium
vs
ZEAL.CO
Zealand Pharma A/S
84
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing shapes this comparison more than a broad operating gap.

Dimension spread: APP vs ZEAL.CO Profitability 100 100 Stability 23 36 Valuation 51 88 Growth 100 100 APP ZEAL.CO
Gap Ranking
#1 Valuation +37
#2 Stability +13
#3 Growth
#4 Profitability
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for APP and ZEAL.CO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer APPZEAL.CO Relative valuation Structural strength

Zealand Pharma A/S and AppLovin Corporation look relatively close on structure, but the price setup still leans toward Zealand Pharma A/S.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Both rank well on valuation, but Zealand Pharma A/S still holds a clear edge.
Stability
Both sit in the weaker half on stability, with Zealand Pharma A/S still coming out ahead.
Valuation — Dominant Gap
APP
51
ZEAL.CO
88
Gap+37in favour of ZEAL.CO

The multiple-based pricing edge comes from a trailing P/E that is 36 turns lower.

What keeps the gap from being one-sided

AppLovin Corporation still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

Valuation is the clearest driver, and stability also supports Zealand Pharma A/S's broader structural position.

Explore full peer positioning in AssetNext

Break down the APP vs ZEAL.CO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-driven comparisons

Explore how APP and ZEAL.CO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.